knowledge -WSS

knowledge

author：knowledge 2025-09-28 01:35:39 - browse：65

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： The United States is paying nearly triple for new Covid vaccines

knowledge

WSS

This gene therapy has record $4.25 million price. It's saved children.

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Nobel honors Karikó and Weissman's enduring partnership

Lawsuit highlights wrinkle for disputes over surprise medical bills

Medical devices makers are asking for forgiveness, not permission

Yancopoulos of Regeneron works to expand Dupixent success

explore

knowledge

hotspot

Supreme Court strikes down use of affirmative action

Setback for rare diseases as Taysha Gene Therapies pulls back

In Memoriam: Notable people who died in 2023

Chinese researcher claims birth of first gene

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Chinese researcher claims birth of first gene

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

23andMe had bad news about my health. I wish a person had delivered it

The United States is paying nearly triple for new Covid vaccines

hotspot

Congress extends some pandemic preparedness programs

Lawsuit highlights wrinkle for disputes over surprise medical bills

Medicare innovation center doesn’t save money, experts say

Medicare Advantage insurers pressure Biden for bigger payments

Yancopoulos of Regeneron works to expand Dupixent success

Nobel honors Karikó and Weissman's enduring partnership

knowledge

hotspot

explore

leisure time